Literature DB >> 17327570

Percutaneous vertebroplasty in the treatment of blastic vertebral column metastasis from breast cancer.

Kieran J Murphy, Ikechi J Nwankwo, Philippe Gailloud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17327570     DOI： 10.1016/j.jvir.2006.12.725

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  6 in total

1.  Safety of percutaneous vertebroplasty for the treatment of metastatic spinal tumors in patients with posterior wall defects.

Authors:  Hongpu Sun; Zuozhang Yang; Yongqing Xu; Xuefeng Liu; Ya Zhang; Yanjin Chen; Da Xu; Yihao Yang; Dongqi Li; Junfeng Xia
Journal:  Eur Spine J       Date:  2015-02-19       Impact factor: 3.134

2.  Clinical investigations on the spinal osteoblastic metastasis treated by combination of percutaneous vertebroplasty and (125)I seeds implantation versus radiotherapy.

Authors:  Zuozhang Yang; Jing Tan; Ruilian Zhao; Jiaping Wang; Hongpu Sun; Xiaoxue Wang; Lei Xu; Hua Jiang; Jinlei Zhang
Journal:  Cancer Biother Radiopharm       Date:  2012-09-25       Impact factor: 3.099

3.  Advances in the clinical research of the minimally invasive treatment for the posterior edge of vertebral-body defects by spinal metastases.

Authors:  Xuefeng Liu; Zuozhang Yang; Lin Xie; Zongqin Yuan; Mingyan Ren; Lei Han
Journal:  Biomed Rep       Date:  2015-06-29

Review 4.  [Cement injection for spinal metastases (vertebroplasty and kyphoplasty)].

Authors:  P F Heini; S Pfäffli
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

Review 5.  Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-05-01

6.  Efficacy of percutaneous vertebroplasty for the relief of osteoblastic spinal metastasis pain.

Authors:  Songfeng Xu; Ting Liu; Xinxin Zhang; Huanmei Liu; Zhenguo Zhao; Libin Xu; Shengji Yu
Journal:  Exp Ther Med       Date:  2021-05-04       Impact factor: 2.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.